Novel Artificial Intelligence Models Detect Type 1 Diabetes Risk Before Clinical Onset


admin

Developments from two studies highlighting the potential for machine learning leveraging artificial intelligence (AI) technology to improve early-stage identification of type 1 diabetes were presented as late-breaking poster sessions at the 85th Scientific Sessions of the American Diabetes Association® (ADA) in Chicago. Each year, around 64,000 Americans are diagnosed with type 1 diabetes. As many […]

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance


admin

FinThrive, Inc., a leading healthcare revenue management software-as-a-service (SaaS) provider, will have a significant presence at the 2025 Healthcare Financial Management Association (HFMA) Annual Conference, which will take place June 22-25 in Denver, Colorado. With high-profile speaking engagements, live demonstrations of cutting-edge solutions, and Agentic AI-driven innovation, FinThrive will showcase how its revenue cycle […]

NeuralCure AI Launches the First Diagnostic & Digital Twin OS for Preventative Care Clinics


admin

NeuralCure AI today announced the official launch of its groundbreaking Diagnostic & Digital Twin Operating System, the first infrastructure platform purpose-built for the exploding preventative, regenerative, and patient-led healthcare market. As millions of Americans take control of their health, ordering their own labs and imaging, using AI to self-navigate symptoms, […]

AllSci Wins Grant to Expand AI Platform for Pharma and Biotech R&D: Accelerating Hypothesis-Driven Discovery


admin

AllSci, a pioneer in AI-driven tools for scientific research, has been awarded a grant from Montgomery County, Maryland’s Technology Innovation Fund – accelerating its mission of making science more accessible, connected, and collaborative. The grant supports AllSci’s continued development of its AI-powered research platform, empowering scientists at every level, from students to senior researchers, to formulate hypotheses, validate […]

Outcomes4Me Acquires Germany’s Mika Health App to Accelerate AI-Driven Patient Empowerment Globally


admin

Outcomes4Me Inc., the developer of the leading, direct-to-patient, AI-driven platform transforming the cancer-care experience, announced today that its German affiliate Outcomes4Me Germany GmbH has acquired the assets associated with the Mika Health app from Berlin-based Fosanis GmbH. The Mika app has served over 100,000 cancer patients globally, and is a clinically […]

Salipro Biotech and Daewoong Pharmaceutical Announce Collaboration Agreement to Advance Development of Novel Therapeutics


admin

Swedish biotech company Salipro Biotech AB today announced that it has entered into a research collaboration with Daewoong Pharmaceutical Co., Ltd. Daewoong Pharmaceutical gains access to Salipro Biotech’s expertise and Salipro® platform for stabilizing challenging membrane proteins (e.g., GPCRs, ion channels, transporters). The collaboration will target a specific membrane protein […]

Spyre Therapeutics Announces Grants of Inducement Awards


admin

Spyre Therapeutics, Inc. a clinical-stage biotechnology company utilizing best-in-class antibody engineering, dose optimization and rational therapeutic combinations to target improved efficacy and convenience in the treatment of IBD and other immune-mediated diseases, today announced that Spyre’s independent Compensation Committee of the Board of Directors approved the grant of stock options […]